Aging facilities contribute to a variety of challenges in pharmaceutical manufacturing, including drug shortages and product recalls. In response to calls for support in this area from industry and regulators, PDA established an Aging Facility Task Force to focus on the identification and modernization of aging facilities, processes and analytics.
To guide the Task Force's efforts, PDA conducted a survey to clarify the meaning of an aging facility, process and analytics and to explore the types and effectiveness of preventative measures. The survey also identified the obstacles encountered when improvements are made and what actions should be taken to overcome potential obstacles.
Available to download
Format: PDF (1 file 1.11 MB)
Click here to view the digital downloading instruction and Terms of Usage
Table of Contents:
Summary of Results
General Information and Demographics
Facility Specific Questions
Product Specific Questions
Aging Facility Defining Questions
Process Specific Question
Improvement Specific Questions